XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net income $ 16,210 $ 19,181
Adjustments to reconcile net income to cash provided by operating activities:    
Deferred income tax provision, net 1,301 8,321
Provision for credit losses 371 172
Depreciation and amortization 1,234 1,093
Stock-based compensation expense 4,326 4,437
Noncash lease expense 1,130 1,502
Loss on equity method investment 750 825
Other 50 358
(Increase) decrease in operating assets    
Trade receivables, net 2,601 (12,914)
Other assets 243 (2,577)
Increase (decrease) in operating liabilities    
Accrued payroll costs (1,230) 15,447
Other liabilities (7,930) 2,897
Cash provided by operating activities 19,056 38,742
Cash flows from investing activities:    
Capital expenditures (1,872) (2,221)
Proceeds from the sale of our joint venture interest 5,059 0
Note receivable issued to our joint venture (750) 0
Equity method investment 0 (500)
Cash provided by (used) in investing activities 2,437 (2,721)
Cash flows from financing activities:    
Proceeds from credit facility 174,200 0
Payments on credit facility (177,500) 0
Repurchases of common stock (11,126) (10,270)
Cash dividends (7,003) (6,094)
Payments on other financing arrangements (14) (19)
Cash used in financing activities (21,443) (16,383)
Change in cash and cash equivalents 50 19,638
Cash and cash equivalents, beginning of period 121 96,989
Cash and cash equivalents, end of period 171 116,627
Cash Paid During the Period For:    
Income taxes 5,108 314
Operating lease liabilities 1,303 1,812
Interest, net 248 547
Non-Cash Investing and Financing Transactions:    
ROU assets obtained from operating leases 566 446
Employee stock purchase plan 245 242
Equipment and software additions included in accounts payable and other accrued liabilities $ 957 $ 0